Price information




Scheduled Reports

Year End Report

Annual General Meeting

About company

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

  • CEO Peter Buhl Jensen
  • Chairm. of the Board Duncan Moore

Instrument Information

  • Full Name
  • Short Name
  • No of shares
  • ISIN code
  • OrderBookID
  • CFI (ISO 10962)
  • FISN (ISO 18774)
  • Par Value kr
  • First Traded
  • Type